How Senescent Cells Affect Cancer Development
Author Information
Author(s): Coppé Jean-Philippe, Patil Christopher K, Rodier Francis, Sun Yu, Muñoz Denise P, Goldstein Joshua, Nelson Peter S, Desprez Pierre-Yves, Campisi Judith
Primary Institution: Lawrence Berkeley National Laboratory
Hypothesis
The study investigates the role of senescence-associated secretory phenotypes (SASPs) in cancer progression and how they are influenced by oncogenic RAS and p53.
Conclusion
The findings suggest that SASPs can promote cancer progression by inducing inflammatory responses and altering the tissue microenvironment.
Supporting Evidence
- Senescent cells secrete factors that can promote inflammation and malignancy.
- SASPs were found to induce an epithelial-mesenchyme transition and invasiveness in nearby cells.
- Oncogenic RAS and loss of p53 significantly amplified the SASP response.
- SASPs were shown to be present in both cultured cells and in vivo after chemotherapy.
- Loss of p53 function led to an accelerated and amplified SASP.
Takeaway
When cells get old and stop dividing, they can send out signals that might help nearby cells become cancerous. This can happen more when certain genes are damaged.
Methodology
The study used antibody arrays to analyze the secretory profiles of senescent cells and compared them across different cell types and conditions.
Potential Biases
Potential bias in the interpretation of SASP effects due to the complexity of cellular interactions in vivo.
Limitations
The study primarily focuses on in vitro models, which may not fully replicate in vivo conditions.
Participant Demographics
The study involved human fibroblast strains and prostate epithelial cells from various donors.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website